These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 203060)

  • 21. The proliferative T cell response to herpes simplex virus (HSV) antigen is restricted by self HLA-D.
    Berle EJ; Thorsby E
    Clin Exp Immunol; 1980 Mar; 39(3):668-75. PubMed ID: 6247109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The HLA system and multiple sclerosis.
    Jersild C
    Birth Defects Orig Artic Ser; 1978; 14(5):123-70. PubMed ID: 99191
    [No Abstract]   [Full Text] [Related]  

  • 23. [HL-A D antigens from B-lymphocytes and susceptibility to certain diseases].
    de Moerloose P; Chardonnens X; Vassalli P; Jeannet M
    Schweiz Med Wochenschr; 1977 Oct; 107(41):1461. PubMed ID: 303374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
    Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
    J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases.
    Lobnig BM; Chantelau E; Vidgrén G; Van Landeghem AA; Kinnunen L; Tuomilehto-Wolf E
    Diabetes Metab; 2002 Jun; 28(3):217-21. PubMed ID: 12149602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.
    Bertrams HJ; Kuwert EK
    J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HLA and multiple sclerosis].
    Govaerts A
    Pathol Biol (Paris); 1986 Jun; 34(6):738-40. PubMed ID: 2876407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of HLA-Dw1 and -Dw2 positive adherent cells in antigen presentation to heterozygous T-cell lines: a low rubella antigen-specific response associated with HLA-Dw2.
    Ilonen J; Salmi A
    Hum Immunol; 1986 Oct; 17(2):94-101. PubMed ID: 2428786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA antigens and mitogen responsiveness in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):187-9. PubMed ID: 300927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cells producing antibody to measles and herpes simplex virus in cerebrospinal fluid and blood of patients with multiple sclerosis and controls.
    Baig S; Olsson O; Olsson T; Löve A; Jeansson S; Link H
    Clin Exp Immunol; 1989 Dec; 78(3):390-5. PubMed ID: 2558823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus.
    Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E
    Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles-specific T cell clones derived from a twin with multiple sclerosis: genetic restriction studies.
    Richert JR; McFarland HF; McFarlin DE; Johnson AH; Woody JN; Hartzman RJ
    J Immunol; 1985 Mar; 134(3):1561-6. PubMed ID: 2578511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
    Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
    Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strong linkage disequilibrium between HLA-Dw2 and and BfS in multiple sclerosis and in the normal population.
    Stewart GJ; Basten A; Kirk RL
    Tissue Antigens; 1979 Aug; 14(2):86-97. PubMed ID: 91230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
    Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
    J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA typing on Italian multiple sclerosis population.
    Zibetti A; Cazzullo CL; Smeraldi E; Scorza-Smeraldi R
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):539-43. PubMed ID: 147093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis immunogenetics: a) associations between HL-A antigens and high measles antibody levels. b) existence of common MLR/immune response determinants in MS patients.
    Cazzullo CL; Smeraldi E
    Boll Ist Sieroter Milan; 1974; 53(5):615-24. PubMed ID: 4282585
    [No Abstract]   [Full Text] [Related]  

  • 38. Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.
    Gronen F; Ruprecht K; Weissbrich B; Klinker E; Kroner A; Hofstetter HH; Rieckmann P
    J Neuroimmunol; 2006 Nov; 180(1-2):185-92. PubMed ID: 17023054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA antigens in patients with recrudescent herpes simplex infections.
    Legendre C; Russell AS; Jeannet M
    Tissue Antigens; 1982 Jan; 19(1):85-9. PubMed ID: 6280337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunogenetic analysis of multiple sclerosis].
    Govaerts A
    Bull Mem Acad R Med Belg; 1983; 138(4):300-5. PubMed ID: 6640186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.